Literature DB >> 32682168

Efficacy of conservative therapy in older people with nonspecific low back pain: A systematic review with meta-analysis and GRADE recommendations.

Lorena K B Amaral1, Mateus B Souza2, Mariana G M Campos3, Vanessa A Mendonça4, Alessandra Bastone5, Leani S M Pereira6, Rodrigo O Mascarenhas7, Vinicius C Oliveira8.   

Abstract

PURPOSE: This systematic review aimed to investigate the effectiveness of conservative therapy in older people with nonspecific low back pain.
MATERIALS AND METHODS: Searches were conducted on Medline, Amed, Embase, Cochrane, Psycinfo and Pedro databases up to 2020. Risk of bias were assessed using the 0-10 PEDro scale. Weighted mean differences (WMDs) or mean differences (MDs) with 95 % confidence intervals (CIs) were reported for each conservative therapy, and strength of the current evidence was assessed using the GRADE approach.
RESULTS: Eleven original trials were included investigating effects on disability, pain, coping, quality of life, strength, balance, depression, falls, sleep quality, mobility, body mass index, percentage body fat, trunk muscle mass and waist-to-hip ratio. Moderate quality evidence showed short-term effects of trigger point acupuncture on disability (WMD = 5.0 points [95 % CI 3.5-6.4] on a 25-point scale) and pain (WMD = 35.9 points [95 % CI 22.2-49.7] on a 101-point scale), and of exercise on disability (WMD = 1.7 points [95 % CI 0.3-3.0]) when compared with control (placebo, sham, waiting list or no intervention). Moderate quality evidence showed no short-term effect of exercise on coping (95 % CI -5.0 to 14.6). Moreover, evidence for other important outcomes in older people is scarce and we did not find any trial investigating pharmacological therapies.
CONCLUSION: Findings support partially exercise and trigger point acupuncture to improve disability and/or pain. Future trials with appropriate sample sizes are likely to impact on the estimates and need to clarify medium- and long-term effects.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Conservative interventions; Effectiveness; Elderly; Idiopathic; Spinal pain

Mesh:

Year:  2020        PMID: 32682168     DOI: 10.1016/j.archger.2020.104177

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  5 in total

Review 1.  Evidence-based recommendations for resistance and power training to prevent frailty in community-dwellers.

Authors:  Hélio José Coelho-Júnior; Marco Carlos Uchida; Anna Picca; Roberto Bernabei; Francesco Landi; Riccardo Calvani; Matteo Cesari; Emanuele Marzetti
Journal:  Aging Clin Exp Res       Date:  2021-02-15       Impact factor: 3.636

Review 2.  Spinal manipulative therapy in older adults with chronic low back pain: an individual participant data meta-analysis.

Authors:  Alan Jenks; Annemarie de Zoete; Maurits van Tulder; Sidney M Rubinstein
Journal:  Eur Spine J       Date:  2022-05-28       Impact factor: 2.721

3.  Acupuncture in chronic aspecific low back pain: a Bayesian network meta-analysis.

Authors:  Alice Baroncini; Nicola Maffulli; Jörg Eschweiler; Friedrich Molsberger; Alexandra Klimuch; Filippo Migliorini
Journal:  J Orthop Surg Res       Date:  2022-06-20       Impact factor: 2.677

4.  The ESCAPE trial for older people with chronic low back pain: Protocol of a randomized controlled trial.

Authors:  Hytalo de Jesus Silva; Leticia Soares Fonseca; Rodrigo Oliveira Mascarenhas; Júlio Pascoal de Miranda; Paulo André Almeida; Mateus Bastos Souza; Leani Souza Maximo Pereira; Murilo Xavier Oliveira; Vinicius Cunha Oliveira
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

Review 5.  Effectiveness of conservative therapy on pain, disability and quality of life for low back pain in pregnancy: A systematic review of randomized controlled trials.

Authors:  Laísa B Maia; Letícia G Amarante; Débora F M Vitorino; Rodrigo O Mascarenhas; Ana Cristina R Lacerda; Bianca M Lourenço; Vinícius C Oliveira
Journal:  Braz J Phys Ther       Date:  2021-07-22       Impact factor: 3.377

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.